July 9, 2018
U.S. Securities and Exchange Commission
Office of Healthcare and Insurance
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
| Attn: | Christine Westbrook Suzanne Hayes |
| Re: | Tilray, Inc. Registration Statement on FormS-1 Filed June 20, 2018 FileNo. 333-225741 |
Dear Ms. Westbrook and Ms. Hayes:
On behalf of Tilray, Inc. (“Tilray” or the “Company”), we submit this letter in response to comments received from the staff (the “Staff”) of the Securities and Exchange Commission (the “Commission”) by letter dated July 2, 2018 (the “Comment Letter”) with respect to the Company’s above referenced Registration Statement on FormS-1 (the “Registration Statement”). Concurrently with the submission of this response letter, the Company is filing Amendment No. 1 to the Registration Statement (“Amendment No. 1”). In addition to addressing the comments raised by the Staff in its letter, the Company has revised Amendment No. 1 to update other disclosures.
For the convenience of the Staff, the numbering of the paragraphs below corresponds to the numbering of the comment in the Comment Letter, the text of which we have incorporated into this response letter for convenience in italicized type and which is followed by the Company’s response. In the responses below, page number references are to Amendment No. 1.
Amendment No. 1 to Registration Statement on FormS-1 filed on June 20, 2018
Business
Adult Use Brands, page 89
| 1. | We note your response to comment 2 and the accompanying qualifying language. However, we do not agree that the product depictions comply with recently reported restrictions related to branding and packaging, including required health warnings, font size, plain packaging using a uniform color, and restrictions on branding that appeals to young people or suggests glamour or excitement. We also note that you have included pictures of edible products that have not been approved for sale. Additionally, the purpose of the registration statement is not to serve as marketing materials for your products. Therefore, the prominence of these graphics are not appropriate because they neither provide nor enhance relevant and meaningful disclosure that investors can use to make an informed investment decision. |
Cooley LLP 1700 Seventh Avenue Suite 1900 Seattle, WA 98101-1355
t: (206)452-8700 f: (206)452-8800 cooley.com
July 9, 2018
Page 2
Response: In response to the Staff’s comment, the Company has removed theadult-use product depictions in Amendment No. 1.
Preliminary Base Prep Prospectus - Appendix 1 Financial Statements
Consolidated and Combined Financial Statements of Tilray Canada Ltd. and Dorada Ventures Ltd.
Independent Auditors’ Report, pageA-35
| 2. | Please provide a consent in your next amendment related to the independent auditors’ report of Frank, Rimerman + Co. LLP. |
Response: In response to the Staff’s comment, the Company has added a consent related to the independent auditors’ report of Frank, Rimerman + Co. LLP. in Amendment No. 1.
Please contact me at (206)452-8756 with any questions or further comments regarding our responses to the Staff’s Comments.
Sincerely,
/s/ Alan Hambelton
Alan Hambelton
| cc: | Brendan Kennedy,Tilray, Inc. |
John Robertson,Cooley LLP
Rob Lando,Osler, Hoskin & Harcourt LLP
Cooley LLP 1700 Seventh Avenue Suite 1900 Seattle, WA 98101-1355
t: (206)452-8700 f: (206)452-8800 cooley.com